Supernus Pharmaceuticals, Inc.
SUPN
$48.27
$1.122.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 372.07M | 384.24M | 308.67M | 281.16M | 522.60M |
| Total Receivables | 211.66M | 182.18M | 187.80M | 171.25M | 140.83M |
| Inventory | 83.92M | 87.06M | 82.39M | 79.40M | 44.02M |
| Prepaid Expenses | 55.85M | 78.09M | 65.33M | 62.08M | 31.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 723.50M | 731.58M | 644.18M | 593.89M | 738.87M |
|
|
|||||
| Total Current Assets | 723.50M | 731.58M | 644.18M | 593.89M | 738.87M |
| Net Property, Plant & Equipment | 35.62M | 36.44M | 37.24M | 39.39M | 32.95M |
| Long-term Investments | 119.43M | 120.67M | 124.88M | 119.08M | 117.02M |
| Goodwill | 119.43M | 120.67M | 124.88M | 119.08M | 117.02M |
| Total Other Intangibles | 469.46M | 549.71M | 569.46M | 623.48M | 481.31M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 80.10M | 62.33M | 76.89M | 43.91M | 12.26M |
| Total Assets | 1.43B | 1.50B | 1.45B | 1.42B | 1.38B |
|
|
|||||
| Total Accounts Payable | 5.59M | 10.17M | 2.68M | 8.18M | 8.22M |
| Total Accrued Expenses | 254.23M | 232.93M | 217.81M | 230.84M | 197.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.74M | 10.64M | 10.61M | 10.79M | 7.39M |
| Total Finance Division Other Current Liabilities | 76.81M | 120.19M | 107.07M | 80.83M | 73.73M |
| Total Other Current Liabilities | 76.81M | 120.19M | 107.07M | 80.83M | 73.73M |
| Total Current Liabilities | 347.38M | 373.93M | 338.17M | 330.63M | 286.36M |
|
|
|||||
| Total Current Liabilities | 347.38M | 373.93M | 338.17M | 330.63M | 286.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 29.43M | 30.27M | 30.37M | 31.42M | 24.38M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.08M | 19.72M | 22.40M | 8.04M | 7.76M |
| Total Liabilities | 396.88M | 423.92M | 390.93M | 370.09M | 318.51M |
|
|
|||||
| Common Stock & APIC | 574.15M | 561.48M | 543.88M | 527.76M | 497.00M |
| Retained Earnings | 457.21M | 515.58M | 517.88M | 521.98M | 567.10M |
| Treasury Stock & Other | -138.00K | -255.00K | -44.00K | -71.00K | -200.00K |
| Total Common Equity | 1.03B | 1.08B | 1.06B | 1.05B | 1.06B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.03B | 1.08B | 1.06B | 1.05B | 1.06B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.03B | 1.08B | 1.06B | 1.05B | 1.06B |
|
|
|||||